Kalaris Therapeutics Inc (KLRS )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol KLRS
- Company Kalaris Therapeutics Inc
- Price $3.87
- Changes Percentage -3.25
- Change -0.13
- Day Low $3.8
- Day High $4.01
- Year High $11.88
- Year Low $2.14
- Market Cap $88,276,725
- Price Avg 50 EMA (D) $5.6
- Price Avg 200 EMA (D) $6.59
- Exchange NASDAQ
- Volume 45,544
- Average Volume 82,282
- Open $3.95
- Previous Close $4
- EPS -0.78
- PE -6.05
- Earnings Announcement 2026-08-12 04:00:00
- Shares Outstanding $18,702,696
Company brief: KALARIS THERAPEUTICS INC (KLRS )
- Healthcare
- Biotechnology
- https://kalaristx.com/
- US
- N/A
- 07-30-2020
- US4829291065
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.